Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1985 1
1986 6
1987 6
1988 6
1989 3
1990 4
1991 4
1993 2
1994 1
1995 1
1996 2
1997 3
1998 1
1999 2
2000 3
2001 1
2002 5
2003 2
2004 6
2005 13
2006 7
2007 6
2008 7
2009 5
2010 4
2011 4
2012 6
2013 14
2014 6
2015 7
2016 4
2017 7
2018 8
2019 6
2020 8
2021 12
2022 11
2023 9
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Curcumin targets in inflammation and cancer.
Deguchi A. Deguchi A. Endocr Metab Immune Disord Drug Targets. 2015;15(2):88-96. doi: 10.2174/1871530315666150316120458. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 25772169 Review.
Lung Tumor Cell Recruitment Assay.
Tomita T, Ieguchi K, Deguchi A, Takita M, Tsukahara F, Hiratsuka S, Maru Y. Tomita T, et al. Among authors: deguchi a. J Vis Exp. 2019 Feb 26;(144). doi: 10.3791/53172. J Vis Exp. 2019. PMID: 30882774
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example.
Maru Y, Tomita T, Deguchi A, Ieguchi K, Takita M, Tsukahara F, Takemura K, Kitao A, Gusovsky F. Maru Y, et al. Among authors: deguchi a. Endocr Metab Immune Disord Drug Targets. 2015;15(2):83-7. doi: 10.2174/187153031502150522123746. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 26004773 Review.
Antibody responses after BNT162b2 vaccination in Japanese geriatric intermediate care facilities.
Suita A, Ohfuji S, Kasamatsu A, Kondo K, Nakata H, Kita T, Deguchi A, Fujimoto M, Iba K, Sakamoto H, Iwasaka K, Sakamoto N, Sakamoto H, Yodoi Y, Kido Y, Nakagama Y, Konishi A, Mukai E, Matsumoto K, Matsuura T, Kase T, Kakeya H, Fukushima W, Hirota Y. Suita A, et al. Among authors: deguchi a. Vaccine X. 2023 Nov 22;15:100412. doi: 10.1016/j.jvacx.2023.100412. eCollection 2023 Dec. Vaccine X. 2023. PMID: 38161985 Free PMC article.
195 results